CLOV vs RAL
Clover Health Investments Corp (CLOV) versus Ralliant Corporation Common Stock (RAL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Ralliant Corporation Common Stock (RAL) is a electronic components company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RAL revenue for 2025-09-26 was $529.1M. Net income was $39.9M. Revenue was up 5.1% from 2025-06-27 to 2025-09-26. RAL currently screens at market cap $7.76B.
CLOV currently screens at market cap $1.55B. RAL currently screens at market cap $7.76B.
Not investment advice. Open the CLOV and RAL stock pages for the full models.
Not investment advice.